Peroxisome proliferator-activated receptors: nuclear control of metabolism

B Desvergne, W Wahli - Endocrine reviews, 1999 - academic.oup.com
B. DNA binding properties C. PPAR ligand-binding properties D. Alternative pathways for
PPAR activation E. PPAR-mediated transactivation properties III. Physiological Aspects A …

Orphan nuclear receptors: from gene to function

V Giguère - Endocrine reviews, 1999 - academic.oup.com
II. Nuclear Receptors: General Concepts A. Anatomy of nuclear receptors B. Mechanisms of
action III. Orphan Nuclear Receptors A. Definition

Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

S Kersten, J Seydoux, JM Peters… - The Journal of …, 1999 - Am Soc Clin Investig
Prolonged deprivation of food induces dramatic changes in mammalian metabolism,
including the release of large amounts of fatty acids from the adipose tissue, followed by …

Regulation of gene expression by dietary fat

DB Jump, SD Clarke - Annual review of nutrition, 1999 - annualreviews.org
▪ Abstract Dietary fat is an important macronutrient for the growth and development of all
organisms. In addition to its role as an energy source and its effects on membrane lipid …

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ

H Lim, RA Gupta, W Ma, BC Paria… - Genes & …, 1999 - genesdev.cshlp.org
We have demonstrated previously that cyclo-oxygenase-2 (COX2), the rate-limiting enzyme
in the biosynthesis of prostaglandins (PGs), is essential for blastocyst implantation and …

A cancer risk assessment of di (2-ethylhexyl) phthalate: application of the new US EPA Risk Assessment Guidelines

J Doull, R Cattley, C Elcombe, BG Lake… - Regulatory Toxicology …, 1999 - Elsevier
The current United States Environmental Protection Agency (EPA) classification of di (2-
ethylhexyl) phthalate (DEHP) as a B2 “probable human” carcinogen is based on outdated …

PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease

N Marx, T Bourcier, GK Sukhova, P Libby… - … , and vascular biology, 1999 - Am Heart Assoc
Plasminogen activator inhibitor type-1 (PAI-1) is a major physiological inhibitor of
fibrinolysis, with its plasma levels correlating with the risk for myocardial infarction and …

The peroxisome proliferator‐activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function

M Ricote, JT Huang, JS Welch… - Journal of leukocyte …, 1999 - Wiley Online Library
Peroxisome proliferator‐activated receptors (PPARs) are ligand‐dependent transcription
factors of the nuclear hormone receptor superfamily, which includes the steroid, retinoid, and …

Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARγ and C/EBPα

AK El-Jack, JK Hamm, PF Pilch, SR Farmer - Journal of Biological …, 1999 - ASBMB
Adipocyte differentiation is regulated by at least two major transcription factors,
CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor …

[PDF][PDF] Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences

PR Holden, JD Tugwood - Journal of molecular endocrinology, 1999 - scholar.archive.org
Peroxisome proliferators (PPs) are chemicals of industrial and pharmaceutical importance
that elicit liver carcinogenesis by a non-genotoxic mechanism. One of the intriguing …